Why the study?
Accurate diagnosis of inherited cardiovascular disorders is complicated by incomplete penetrance and variable expressivity. Because expertise in genomic interpretation of these disorders is lacking in India, there is a pressing need for specialized inherited cardiovascular disease clinics.
Does a specialized inherited cardiovascular disease clinic utilizing genetic testing and multidisciplinary reanalysis improve the diagnostic yield of causative genetic variants in patients with suspected inherited cardiovascular diseases in India?
Observational (n=41)
No
Does a specialized inherited cardiovascular disease clinic utilizing genetic testing and multidisciplinary reanalysis improve the diagnostic yield of causative genetic variants in patients with suspected inherited cardiovascular diseases in India?
Standard commercial genetic testing in India identifies a causative variant in roughly half of patients with suspected inherited cardiovascular diseases, while expert multidisciplinary reanalysis can uncover additional missed diagnoses.
Answers are grounded in this paper and cite their sources.
Multidisciplinary reanalysis may raise diagnostic yield in inherited CVD; leaves open generalizability and need for prospective validation.
Background: Inherited cardiovascular disorders are a group of cardiac conditions with Mendelian inheritance pattern. Our understanding of the genetic basis of these disorders continues to evolve. Accurate diagnosis of these disorders is complicated by incomplete penetrance and variable expressivity. Expertise in the genomic interpretation of these disorders is lacking in India, and there is a pressing need to set up specialized inherited cardiovascular disease clinics to manage these conditions. Methods: This was a retrospective case record analysis of all patients evaluated for a suspected inherited cardiovascular disease at one clinic between May 2020 and August 2022. All patients underwent a detailed evaluation, including history, a three-generation pedigree, clinical examination, electrocardiogram, and echocardiogram. Pretest genetic counselling was provided by an experienced physician or nurse. Genetic testing was performed in a commercial or research facility from the peripheral venous blood or amniotic fluid of affected fetuses. Results: During the study period, a total of 41 patients were evaluated for a possible inherited cardiovascular disease. The indication for testing included channelopathy ( n = 4), hypertrophic cardiomyopathy ( n = 7), dilated cardiomyopathy ( n = 6), aortopathies ( n = 7), pulmonary arterial hypertension (n = 6), familial hypercholesterolemia ( n = 1), disorders of laterality ( n = 5), and inherited congenital heart defects ( n = 5). All except two samples were processed in a commercial laboratory. A pathogenic or likely pathogenic variant consistent with the clinical phenotype was identified in 22 patients. After reanalysis of the genetic data by a team consisting of a pediatric cardiologist, a molecular geneticist, and a data scientist with a special interest in inherited cardiovascular diseases, along with inputs from a designated global expert, a causative variant missed in the initial testing was identified in seven other children. Testing of three other patients is currently underway, while the data of five other patients is currently under review. The subsets with the lowest positivity rate include dilated cardiomyopathy and aortopathy other than Marfan syndrome. Conclusions: Current genetic testing methods yield a positive diagnosis in roughly half of patients with suspected inherited cardiovascular diseases who underwent a thorough pretesting evaluation. There are gaps in molecular expertise in the commercial laboratories in India. Clinicians need to take cognizance of this fact and continue to pursue further evaluation even if commercial testing fails to yield a positive result.
No takes yet. Share an insight, caveat, or question.
Krishna et al. (2026) conducted an observational in Inherited cardiovascular diseases (n=41). Genetic testing with multidisciplinary expert reanalysis vs. Initial commercial or research laboratory genetic testing was evaluated on Identification of a pathogenic or likely pathogenic genetic variant consistent with the clinical phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: